Multivariate analysis showed that NDRG4 could be a prognostic factor for overall survival of patients with colorectal cancer independent of gender, age, differentiation status, TNM stage, KRAS, BRAF and PIK3CA mutations and MSI status. This evidence concerns the gene KRAS and colorectal cancer.